{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:49Z","timestamp":1792691149688,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":6210,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1194\/jlr.m300041-jlr200","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T13:54:58Z","timestamp":1064325298000},"page":"1692-1697","source":"Crossref","is-referenced-by-count":30,"title":["Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen"],"prefix":"10.1016","volume":"44","author":[{"given":"Jean Michel","family":"Petit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Florentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Duvillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chavanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marcel","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Portier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M300041-JLR200_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M300041-JLR200_bib2","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet."},{"key":"10.1194\/jlr.M300041-JLR200_bib4","first-page":"547","article-title":"Protease inhibitors, diabetes mellitus and blood lipids","volume":"24","author":"Meyer","year":"1998","journal-title":"Diabetes Metab."},{"key":"10.1194\/jlr.M300041-JLR200_bib5","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001432-199902000-00003","article-title":"Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndrome","volume":"12","author":"Martinez","year":"1999","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1194\/jlr.M300041-JLR200_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-978655","article-title":"HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study","volume":"32","author":"Petit","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1194\/jlr.M300041-JLR200_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.M300041-JLR200_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041433-200106000-00011","article-title":"Antiretroviral therapy\u2013associated hyperlipidemia in HIV disease","volume":"12","author":"Mooser","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M300041-JLR200_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042560-200201010-00003","article-title":"Body habitus changes and metabolic alterations in protease inhibitor-naive HIV 1-infected patients treated with two nucleoside reverse transcriptase inhibitors","volume":"29","author":"Galli","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1194\/jlr.M300041-JLR200_bib11","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1086\/338811","article-title":"Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients","volume":"34","author":"Ch\u00eane","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1194\/jlr.M300041-JLR200_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00126334-200107010-00005","article-title":"Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy","volume":"27","author":"Duong","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1194\/jlr.M300041-JLR200_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1194\/jlr.M300041-JLR200_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1194\/jlr.M300041-JLR200_bib17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet."},{"key":"10.1194\/jlr.M300041-JLR200_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s001250050004","article-title":"Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes","volume":"43","author":"Duvillard","year":"2000","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.M300041-JLR200_bib19","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.ATV.0000032134.92180.41","article-title":"Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity","volume":"22","author":"Pont","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M300041-JLR200_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.M300041-JLR200_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a post-prandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"10.1194\/jlr.M300041-JLR200_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/diab.39.9.1017","article-title":"Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM","volume":"39","author":"Taskinen","year":"1990","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M300041-JLR200_bib23","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0022-2275(20)39934-X","article-title":"In vivo metabolism of apolipoprotein A-IV in severe hypertriglyceridemia: a combined radiotracer and stable isotope kinetic study","volume":"35","author":"Verg\u00e8s","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M300041-JLR200_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"537","author":"Martinez","year":"2001","journal-title":"Lancet."},{"key":"10.1194\/jlr.M300041-JLR200_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib26","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M300041-JLR200_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00126334-200103010-00004","article-title":"Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy","volume":"26","author":"Schmitz","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1194\/jlr.M300041-JLR200_bib28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1194\/jlr.M200129-JLR200","article-title":"The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice","volume":"43","author":"Riddle","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M300041-JLR200_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00002030-200207050-00010","article-title":"Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine","volume":"16","author":"Negredo","year":"2002","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s001250050700","article-title":"Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM","volume":"40","author":"Malmstr\u00f6m","year":"1997","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.M300041-JLR200_bib31","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS."},{"key":"10.1194\/jlr.M300041-JLR200_bib32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"12","author":"Liang","year":"2001","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M300041-JLR200_bib33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-2275(20)41973-X","article-title":"De novo production of low density lipoproteins: fact or fancy","volume":"32","author":"Shames","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M300041-JLR200_bib34","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520337329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520337329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M300041-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T17:43:28Z","timestamp":1637430208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520337329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0022227520337329"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m300041-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}